Loading...

Overall and comparative safety of biologic and immunosuppressive therapy in inflammatory bowel diseases

INTRODUCTION: Efficacy and safety are key aspects when choosing therapies for patients with inflammatory bowel diseases (IBD). While several randomized trials and indirect comparisons have informed the comparative efficacy of medications, there has been limited synthesis of safety of different agent...

Full description

Saved in:
Bibliographic Details
Published in:Expert Rev Clin Immunol
Main Authors: Holmer, Ariela, Singh, Siddharth
Format: Artigo
Language:Inglês
Published: 2019
Subjects:
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6813772/
https://ncbi.nlm.nih.gov/pubmed/31322018
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/1744666X.2019.1646127
Tags: Add Tag
No Tags, Be the first to tag this record!